Retinoic acid as a novel medical therapy for Cushing's disease in dogs. - Wikidata - awgldk - TriplyDB

Retinoic acid as a novel medical therapy for Cushing's disease in dogs.

Retinoic acid as a novel medical therapy for Cushing's disease in dogs.

http://www.wikidata.org/entity/Q34533079

about

Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement.Update in the medical therapy of Cushing's disease The Treatment of Cushing's Disease.Effects of Carbenoxolone on the Canine Pituitary-Adrenal Axis Prolactinomas, Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas.Medical treatment of Cushing's disease: Overview and recent findings.Update on medical treatment for Cushing's disease.Cellular and molecular specificity of pituitary gland physiology.Pharmacological management of Cushing's syndrome: an update.EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas.Effects of RXR Agonists on Cell Proliferation/Apoptosis and ACTH Secretion/Pomc Expression.The Role of Isotretinoin Therapy for Cushing's Disease: Results of a Prospective Study.Expression and functional analysis of dopamine receptor subtype 2 and somatostatin receptor subtypes in canine cushing's disease Endocrine clinical update: where are we in the therapeutic management of pituitary-dependent hypercortisolism?New avenues in the medical treatment of Cushing's disease: corticotroph tumor targeted therapy Targeting pituitary tumors.The corticotropin-releasing hormone network and the hypothalamic-pituitary-adrenal axis: molecular and cellular mechanisms involved.Mifepristone: is there a place in the treatment of Cushing's disease?Recent developments in drug therapy for Cushing's disease.Molecular basis of pharmacological therapy in Cushing's disease.Post-surgical treatment of thyroid carcinoma in dogs with retinoic acid 9 cis improves patient outcome.Pituitary-directed medical therapy in Cushing's disease.Emerging drugs for Cushing's disease.Currently used and investigational drugs for Cushing´s disease.Effect of SOM230 (pasireotide) on corticotropic cells: action in dogs with Cushing's disease.Proliferation, angiogenesis and differentiation related markers in compact and follicular-compact thyroid carcinomas in dogs.All-trans retinoic acid and a novel synthetic retinoid tamibarotene (Am80) differentially regulate CD38 expression in human leukemia HL-60 cells: possible involvement of protein kinase C-delta.AT-101 acts as anti-proliferative and hormone suppressive agent in mouse pituitary corticotroph tumor cells.Histone Deacetylase Inhibitor SAHA Is a Promising Treatment of Cushing Disease.Pituitary-Directed Therapies for Cushing's Disease.New Insights in Cushing Disease Treatment With Focus on a Derivative of Vitamin A.Metformin reduces insulin resistance and the tendency toward hyperglycaemia and dyslipidaemia in dogs with hyperadrenocorticism.

P2860

Q24629410-56CCD4A8-3717-4670-B334-AB1559880E4C Q26865203-7096D71E-ABC7-49F0-AB05-42C0985A432A Q27010590-C8CA5FDD-E55E-470A-8FB7-5A8E3B0491F1 Q28547156-E0269F7C-ED88-49D9-BB07-5BC9CF1179CE Q33579615-D4FF6B7D-BE78-419C-8240-4EFEA793601B Q33735039-CA37786A-F71A-4AC8-A181-800E9F00E600 Q33802284-3264E3B0-509D-4E97-80B2-8A13A3C9683C Q34251305-C042E78B-13FB-485A-A92A-392324B023D0 Q34587379-C8E50BF0-0294-448A-A3BA-7C644F007D83 Q35578652-E377E899-EE4B-4165-8120-F8E030684D33 Q35880635-7CCE3FDC-4C04-4B65-A97A-4F232801C067 Q36681083-DA4CA576-3D53-4D76-82CF-BB0C7C769945 Q36908926-36E625D6-121B-4128-A2E0-AF5AE3BFA9D8 Q36940053-B3F1352B-4293-42E2-B9C3-C72E5D10F046 Q37049132-59724B26-EB8C-4F95-81E9-F3A816E05C94 Q37050089-DA472101-8C87-4209-A3D5-6019BB823177 Q37876094-10CB849B-5929-4456-BE8D-5CA9D01AF2B5 Q38063404-0090B0C7-CC35-4B9C-9AE0-CB962C0D0DC5 Q38112082-1F5FA47F-25CF-4A51-A931-8C88D512DFC3 Q38165863-8B54E220-60EC-435F-B44F-7FB991EFF870 Q38274255-2AE9D436-6A2E-4EFC-9C59-765446732304 Q38334659-AB2BC6CE-23B9-44B5-A3C1-5B71032FC3B3 Q38505947-BAA3F7C6-CF93-4874-A28D-D21DFF724533 Q39022297-C4FFC479-38F9-4DBC-BB79-35C30F919260 Q39551743-14855674-07BA-4317-87B9-AC78BD41BC63 Q41097428-B912016F-3C04-46FE-A4FC-FD73C2706A38 Q42746486-EFAF4E22-BF2E-4E1B-B470-0911B3E9BF8E Q50524034-49E1C1F9-8E23-48C7-88D2-7BB53402C8C7 Q50646949-ABA12E27-60DA-4748-BE9E-E0520AAA904C Q54961209-188B400E-75D9-46A5-83DB-2F6F3088D173 Q55249109-4DA12A47-1880-4D8B-BFFE-D05F0385210F Q55342484-DE322624-4AE7-47E5-A07A-189FD5276319

P2860

Retinoic acid as a novel medical therapy for Cushing's disease in dogs.

http://www.wikidata.org/entity/Q34533079

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

name

Retinoic acid as a novel medical therapy for Cushing's disease in dogs.

@ast

Retinoic acid as a novel medical therapy for Cushing's disease in dogs.

@en

Retinoic acid as a novel medical therapy for Cushing's disease in dogs.

@nl

type

label

Retinoic acid as a novel medical therapy for Cushing's disease in dogs.

@ast

Retinoic acid as a novel medical therapy for Cushing's disease in dogs.

@en

Retinoic acid as a novel medical therapy for Cushing's disease in dogs.

@nl

prefLabel

Retinoic acid as a novel medical therapy for Cushing's disease in dogs.

@ast

Retinoic acid as a novel medical therapy for Cushing's disease in dogs.

@en

Retinoic acid as a novel medical therapy for Cushing's disease in dogs.

@nl

P1433

Q34533079-7CE96F5D-CA82-481A-A185-D7E2A1CCBFE3

P1476

Q34533079-EC582858-8E48-4E06-86E3-54A090572D0C

P2093

Q34533079-0610EB6E-C779-4A13-85CD-2EB97BFAC999

Q34533079-2DEC49B6-5A04-4D40-B0EC-5533E1AEB5DD

Q34533079-44ADC837-2052-4AE0-972F-2CA25281C4EF

Q34533079-755C78BA-CF17-40B7-BEFA-B1E3535CE03F

Q34533079-A66F13AD-2FDF-42AC-BA68-4AF6B1A91A95

Q34533079-B6C733FB-F894-44A2-B580-D465C8EB9CC4

Q34533079-B82F9AC1-354B-4C45-8B7E-BC3EAD900241

Q34533079-D1D7072E-99BC-4F9F-B439-A76509D40321

Q34533079-D2236737-DB11-43C5-898C-27D2553E0F97

P304

Q34533079-4D395AA3-A671-4102-8F77-6CD651B6A4DF

P31

Q34533079-F4DB9744-FD64-4215-92A5-FDE0099D6707

P356

Q34533079-A83EBE1E-EE66-4E3A-BD38-B61573BADA70

P407

Q34533079-9A9B50A9-B239-496E-9F03-D066973B8B5D

P433

Q34533079-432AC417-22AA-4F59-87F7-6302D9E5A40D

P478

Q34533079-03F2E302-5F9E-4B33-9B69-0E4AE93CAC03

P50

Q34533079-4AAF993A-ECF8-4F43-8163-3EA47A320FF1

Q34533079-892BFDE5-EC60-4B43-B706-A44516E9E32E

Q34533079-C859D257-75D6-4953-8E91-55EB72A818F7

Q34533079-F11AC1ED-CD20-4402-9367-632EF08EC144

P577

Q34533079-CD368F43-48FE-4E3E-BAC7-05CA65691D3F

P698

Q34533079-724E726B-778A-4ECE-93CD-8FBC1D7767B4

P356

P1433

P1476

Retinoic acid as a novel medical therapy for Cushing's disease in dogs.

@en

P2093

Ashley B Grossman

http://www.w3.org/2001/XMLSchema#string

Damiana Giacomini

http://www.w3.org/2001/XMLSchema#string

Eduardo Arzt

http://www.w3.org/2001/XMLSchema#string

Günter K Stalla

http://www.w3.org/2001/XMLSchema#string

Johanna Stalla

http://www.w3.org/2001/XMLSchema#string

Marcelo Páez-Pereda

http://www.w3.org/2001/XMLSchema#string

Marily Theodoropoulou

http://www.w3.org/2001/XMLSchema#string

Marta Labeur

http://www.w3.org/2001/XMLSchema#string

Victor Castillo

http://www.w3.org/2001/XMLSchema#string

P304

4438-4444

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/EN.2006-0414

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

147

http://www.w3.org/2001/XMLSchema#string

P50

Florian Holsboer

Marily Theodoropoulou

Damiana Giacomini

P577

2006-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16740975

http://www.w3.org/2001/XMLSchema#string